Segall Bryant & Hamill LLC Sells 897 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Segall Bryant & Hamill LLC lessened its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 1.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 66,747 shares of the company’s stock after selling 897 shares during the quarter. Segall Bryant & Hamill LLC owned approximately 0.08% of HealthEquity worth $6,404,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in HQY. Charles Schwab Investment Management Inc. grew its holdings in HealthEquity by 1.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,061,807 shares of the company’s stock worth $86,909,000 after acquiring an additional 14,532 shares during the period. Raymond James Trust N.A. grew its stake in HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after purchasing an additional 132 shares during the period. Citigroup Inc. increased its holdings in HealthEquity by 73.0% in the third quarter. Citigroup Inc. now owns 102,107 shares of the company’s stock worth $8,357,000 after purchasing an additional 43,084 shares in the last quarter. Cerity Partners LLC lifted its stake in HealthEquity by 15.1% in the third quarter. Cerity Partners LLC now owns 17,259 shares of the company’s stock valued at $1,413,000 after buying an additional 2,258 shares during the period. Finally, BNP Paribas Financial Markets boosted its holdings in shares of HealthEquity by 165.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company’s stock worth $1,673,000 after buying an additional 12,745 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.20% of the stock is owned by insiders.

Analysts Set New Price Targets

HQY has been the topic of a number of research reports. KeyCorp dropped their target price on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Monday. Barrington Research reiterated an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a report on Friday, March 14th. Mizuho began coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective on the stock. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their target price for the company from $120.00 to $115.00 in a research report on Tuesday. Finally, Wells Fargo & Company increased their price target on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $113.31.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $89.22 on Thursday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a market cap of $7.72 billion, a PE ratio of 81.85, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The stock’s fifty day simple moving average is $104.17 and its two-hundred day simple moving average is $95.89. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.